Skip to content

Predicting Post-Cardiac Surgery Acute Kidney Disease: A Machine Learning Approach

Development and Validation of a Machine Learning-Based Risk Prediction Model for Acute Kidney Disease After Cardiac Surgery

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07482683
Enrollment
820
Registered
2026-03-19
Start date
2026-03-01
Completion date
2027-06-30
Last updated
2026-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Disease

Brief summary

Renal injury after cardiac surgery is one of the common complications with high incidence rate, high risk of death and progression to chronic kidney disease (CKD). Previous evaluations of perioperative renal function mainly focused on acute kidney injury (AKI) related to cardiac surgery within seven days after surgery. The newly proposed concept of acute kidney disease (AKD) in recent years refers to acute or subacute kidney injury lasting seven to ninety days. Research has found that AKD can occur after AKI or in patients without AKI, and the two are both related and independent of each other, possibly indicating different subtypes of kidney injury. AKD is not uncommon and is a more significant predictor of mortality and end-stage kidney disease (ESKD). Therefore, AKD may be an important window for identifying and managing high-risk patients after cardiac surgery. Due to limited research on AKD after cardiac surgery, the risk factors for AKD are currently unclear, and there are no clinically practical and effective risk stratification tools available. This study aims to establish a multimodal perioperative data platform through a retrospective cohort, and use machine learning methods to construct a risk prediction model for AKD after cardiac surgery. The accuracy and stability of the model will be validated in a prospective study cohort, and an online risk prediction and clinical decision-making tool will be developed to help clinicians quickly conduct personalized risk assessments and optimize diagnosis and treatment strategies, thereby improving patient prognosis and reducing medical costs.

Interventions

None listed

Sponsors

China National Center for Cardiovascular Diseases
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years; * Undergoing coronary artery bypass grafting and/or heart valve surgery, with or without aortic surgery; * Baseline serum creatinine level \< 354 umol/L; * Informed consent obtained.

Exclusion criteria

* Emergency surgery; * Multiple surgeries or reoperation; * End-stage kidney disease (ESKD), renal replacement therapy, or kidney transplantation; * Occurrence of AKI within 1 week before surgery or unresolved AKI; * Death within 1 week after surgery.

Design outcomes

Primary

MeasureTime frame
Number of Participants with acute kidney disease after cardiac surgery Assessed by KDIGO guidelinewithin 90 days after cardiac surgery
acute kidney disease after cardiac surgerywithin 90 days after cardiac surgery

Countries

China

Contacts

CONTACTLili Liu
lll9536@sina.com86-010-88396533

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026